Featured expert

William Nadeau, MS, RD
Medical Affairs Director, Cardinal Health
Hospital-acquired venous thromboembolism (HA-VTE) is a common, costly and preventable hospital complication.
Bleeding is a potential complication associated with the use of pharmacological prevention for VTE.
IPC can be seen as a cost-saving in the prevention of VTE after general surgery1
$113 cost saving per patient2
Treating post-operative general surgery patients with moderate to high risk of VTE with IPC
A cost effectiveness model for patients was created with moderate to high risk of VTE after general surgery. It compared two hypothetical groups of 1000 patients treated with IPC plus graduated compression stockings (GCS) or no prophylaxis. The primary endpoints included cost of treating VTE and cost of prophylaxis per 1000 patients.1